Domoprednate Explained

Domoprednate (brand name Stermonid; developmental code name Ro 12-7024) is a synthetic glucocorticoid corticosteroid which was developed in the late 1970s and 1980s.[1] [2] [3] [4] [5]

Notes and References

  1. Book: J. Elks. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. 14 November 2014. Springer. 978-1-4757-2085-3. 465–.
  2. Schmidt H, Hjorth N, Holm P . A randomized trial on the D-homosteroid domoprednate (Ro 12-7024) in the treatment of dermatoses . Dermatologica . 168 . 3 . 127–30 . 1984 . 10.1159/000249683 . 6370748 .
  3. Serup J, Holm P . Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo . Dermatologica . 170 . 4 . 189–94 . 1985 . 10.1159/000249529 . 3888708 .
  4. Christiansen JV, Foged E, Holm P, Jørgensen AS, Reymann F . The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial . Dermatologica . 170 . 4 . 195–8 . 1985 . 10.1159/000249530 . 3888709 .
  5. Schmidt H, Hjorth N, Holm P . Domoprednate, a new nonhalogenated topical steroid: comparison to hydrocortisone butyrate . Dermatologica . 175 . 3 . 145–7 . 1987 . 10.1159/000248813 . 3653463 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Domoprednate".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.